Merrill A. McPeak, Director at IOVANCE BIOTHERAPEUTICS, INC. (IOVA), bought 10,000 shares at $6.15 ($62K) on 2022-12-21, disclosed to the SEC on 2022-12-22.
Open-market purchase of $62k IOVA by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Something here stands out, but not much.
| Filing → |
| IOVA | BUY | 2022-11-30 | $126K | — | Filing → |
| IOVA | BUY | 2022-11-28 | $62K | — | Filing → |
| IOVA | BUY | 2022-06-02 | $136K | — | Filing → |